glp-1 attorney (formerly Ozempic) Case Criteria Guide Chicago attorney Matt Williams discusses
Description
To improve sluggish sales, GSK tried to lower prices of Tanzeum

J Biol Chem 270: 26488-26496, 1995

At USD 1,349 per month list price for Wegovy and USD 1,059 for Zepbound, monthly GLP-1 obesity drug costs create absolute financial barriers for the 62% of obesity patients enrolled in Medicaid, Medicare, or underinsured commercial plans without anti-obesity medication benefits

The test ($99) identifies your genetic predispositions across 14 metabolic pathwaysincluding GIPR, GLP1R, FTO, and MC4R variantsto predict which GLP-1 medication and starting dose will work best for you

Many of our patients come to us with real questions, real concerns, and a desire for straight answers

Ongoing support: Coaching and telehealth to help you stay on track